Zhanfeng Cui BSc MSc PhD MA DSc FREng CEng MIPEM CSci MIPEM FAIMB FIChemE, FREng

2000-Present: Donald Pollock Professor of Chemical Engineering, Oxford University

2000-Present: Fellow of Hertford College, Oxford

Oct. 1999 - 2000: Reader in Engineering Science, Oxford University

Oct. 1994 - Sept 2000: Fellow and Engineering Tutor, Keble College, Oxford

Oct. 1994 - Sept 1999: University Lecturer in Engineering Science, Oxford University

March 1991 - Sept 1994: Lecturer, Department of Chemical Engineering, University of Edinburgh

May. 1990 - Feb. 1991: Research Fellow, Department of Pharmacy, University of Strathclyde

Oct.1988 - April 1990: Research Associate, Bioengineering Unit, University of Strathclyde, UK

DSc, 2009, University of Oxford

MA, 1994, Keble College, Oxford

PhD in Chemical Engineering,1987, Dalian University of Technology (China)

MSc in Chemical Engineering, 1984, Dalian University of Technology (China)

BSc in Chemical Engineering, 1982, Inner Mongolia Polytechnic University (China)

Zhanfeng is also Editor in Chief of the Bio-Design and Manufacturing journal.

He is Academic Founder of Oxford MEStar Limited (a spin-out company specialising in translational and regenerative medicine) and CN BioInnovation Limited, one of the pre-eminent Organ-on-Chip firms.

Oxford SimCell Limited, a company targeting cancer screening and therapies

Oxsed Limited  ( link to oxsed.com),   a social venture company to commercialise OxLAMP^TMtechnology for Covid-19 rapid testing

Webinar on Rapid Testing Kits and International Collaboration

• Regenerative Medical Engineering and Technologies
• Biomanufacture,  Bioprocessing,  and Bioformulation
• Medical devices for detecting infectious diseases including Covid-19 and cancer